Hrt Financial LP Quanterix Corp Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$12.26 - $23.78 $266,409 - $516,739	-21,730 Reduced 64.88%	11,761 $155,000
Q1 2024 May 13, 2024	SELL	$21.9 - $28.28 $35,937 - $46,407	-1,641 Reduced 4.67%	33,491 $789,000
Q4 2023 Feb 09, 2024	BUY	$19.54 - $28.66 $343,532 - $503,871	17,581 Added 100.17%	35,132 $960,000
Q3 2023 Nov 13, 2023	BUY	$21.15 - $27.96 $371,203 - $490,725	17,551 New	17,551 $476,000
Q1 2023 May 12, 2023	BUY	$10.12 - $14.91 $226,789 - $334,133	22,410 New	22,410 $252,000
Q3 2022 Nov 14, 2022	BUY	$7.46 - $19.28 $178,331 - $460,888	23,905 New	23,905 $263,000

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.